Vanguard Group Inc Cryo Cell International Inc Transaction History
Vanguard Group Inc
- $6.44 Trillion
- Q3 2025
A detailed history of Vanguard Group Inc transactions in Cryo Cell International Inc stock. As of the latest transaction made, Vanguard Group Inc holds 150,991 shares of CCEL stock, worth $625,102. This represents 0.0% of its overall portfolio holdings.
Number of Shares
150,991
Previous 129,814
16.31%
Holding current value
$625,102
Previous $673,000
3.12%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding CCEL
# of Institutions
21Shares Held
1.01MCall Options Held
0Put Options Held
0-
Hamilton Lane Advisors LLC410KShares$1.7 Million1.37% of portfolio
-
Sfi Advisors, LLC Montclair, NJ165KShares$684,3420.51% of portfolio
-
Massmutual Trust CO Fsb111KShares$459,6840.01% of portfolio
-
Geode Capital Management, LLC Boston, MA53.4KShares$221,1420.0% of portfolio
-
Northern Trust Corp Chicago, IL28.7KShares$118,8840.0% of portfolio
About CRYO CELL INTERNATIONAL INC
- Ticker CCEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Care Facilities
- Shares Outstandng 8,519,250
- Market Cap $35.3M
- Description
- Cryo-Cell International, Inc. engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative med...